nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefoxitin—Azotaemia—Vincristine—sarcoma	0.0198	0.0198	CcSEcCtD
Cefoxitin—Induration—Etoposide—sarcoma	0.0191	0.0191	CcSEcCtD
Cefoxitin—Local reaction—Mitoxantrone—sarcoma	0.0186	0.0186	CcSEcCtD
Cefoxitin—Nephropathy toxic—Mitoxantrone—sarcoma	0.0179	0.0179	CcSEcCtD
Cefoxitin—Bone marrow depression—Vincristine—sarcoma	0.0156	0.0156	CcSEcCtD
Cefoxitin—Bone marrow depression—Mitoxantrone—sarcoma	0.0152	0.0152	CcSEcCtD
Cefoxitin—Nephropathy toxic—Etoposide—sarcoma	0.0149	0.0149	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Thiotepa—sarcoma	0.0126	0.0126	CcSEcCtD
Cefoxitin—Prothrombin level increased—Epirubicin—sarcoma	0.0117	0.0117	CcSEcCtD
Cefoxitin—Colitis—Thiotepa—sarcoma	0.0114	0.0114	CcSEcCtD
Cefoxitin—Aplastic anaemia—Dactinomycin—sarcoma	0.0111	0.0111	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Mitoxantrone—sarcoma	0.0109	0.0109	CcSEcCtD
Cefoxitin—Prothrombin level increased—Doxorubicin—sarcoma	0.0108	0.0108	CcSEcCtD
Cefoxitin—Phlebitis—Dactinomycin—sarcoma	0.00996	0.00996	CcSEcCtD
Cefoxitin—Vaginal moniliasis—Epirubicin—sarcoma	0.00951	0.00951	CcSEcCtD
Cefoxitin—Vulvovaginal candidiasis—Epirubicin—sarcoma	0.00912	0.00912	CcSEcCtD
Cefoxitin—Vaginal moniliasis—Doxorubicin—sarcoma	0.0088	0.0088	CcSEcCtD
Cefoxitin—Vulvovaginal mycotic infection—Epirubicin—sarcoma	0.00877	0.00877	CcSEcCtD
Cefoxitin—Phlebitis—Mitoxantrone—sarcoma	0.00867	0.00867	CcSEcCtD
Cefoxitin—Local reaction—Epirubicin—sarcoma	0.00866	0.00866	CcSEcCtD
Cefoxitin—Vulvovaginal candidiasis—Doxorubicin—sarcoma	0.00844	0.00844	CcSEcCtD
Cefoxitin—Candida infection—Etoposide—sarcoma	0.00817	0.00817	CcSEcCtD
Cefoxitin—Vulvovaginal mycotic infection—Doxorubicin—sarcoma	0.00812	0.00812	CcSEcCtD
Cefoxitin—Renal failure acute—Mitoxantrone—sarcoma	0.00809	0.00809	CcSEcCtD
Cefoxitin—Local reaction—Doxorubicin—sarcoma	0.00802	0.00802	CcSEcCtD
Cefoxitin—Rash maculo-papular—Etoposide—sarcoma	0.00778	0.00778	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Dactinomycin—sarcoma	0.00773	0.00773	CcSEcCtD
Cefoxitin—Phlebitis—Etoposide—sarcoma	0.00721	0.00721	CcSEcCtD
Cefoxitin—Bone marrow depression—Epirubicin—sarcoma	0.00711	0.00711	CcSEcCtD
Cefoxitin—Pancytopenia—Thiotepa—sarcoma	0.0071	0.0071	CcSEcCtD
Cefoxitin—Pancytopenia—Dactinomycin—sarcoma	0.00704	0.00704	CcSEcCtD
Cefoxitin—Neutropenia—Dactinomycin—sarcoma	0.00694	0.00694	CcSEcCtD
Cefoxitin—Bone marrow depression—Doxorubicin—sarcoma	0.00657	0.00657	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Dactinomycin—sarcoma	0.00656	0.00656	CcSEcCtD
Cefoxitin—Jaundice—Thiotepa—sarcoma	0.0065	0.0065	CcSEcCtD
Cefoxitin—Pancytopenia—Vincristine—sarcoma	0.00629	0.00629	CcSEcCtD
Cefoxitin—Agranulocytosis—Thiotepa—sarcoma	0.00622	0.00622	CcSEcCtD
Cefoxitin—Neutropenia—Vincristine—sarcoma	0.0062	0.0062	CcSEcCtD
Cefoxitin—Agranulocytosis—Dactinomycin—sarcoma	0.00617	0.00617	CcSEcCtD
Cefoxitin—Pancytopenia—Mitoxantrone—sarcoma	0.00613	0.00613	CcSEcCtD
Cefoxitin—Neutropenia—Mitoxantrone—sarcoma	0.00604	0.00604	CcSEcCtD
Cefoxitin—Haemoglobin—Thiotepa—sarcoma	0.00601	0.00601	CcSEcCtD
Cefoxitin—Haemorrhage—Thiotepa—sarcoma	0.00598	0.00598	CcSEcCtD
Cefoxitin—Urinary tract disorder—Thiotepa—sarcoma	0.00591	0.00591	CcSEcCtD
Cefoxitin—Urethral disorder—Thiotepa—sarcoma	0.00586	0.00586	CcSEcCtD
Cefoxitin—Erythema multiforme—Dactinomycin—sarcoma	0.00561	0.00561	CcSEcCtD
Cefoxitin—Jaundice—Mitoxantrone—sarcoma	0.00561	0.00561	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Etoposide—sarcoma	0.00559	0.00559	CcSEcCtD
Cefoxitin—Flushing—Dactinomycin—sarcoma	0.00551	0.00551	CcSEcCtD
Cefoxitin—Agranulocytosis—Mitoxantrone—sarcoma	0.00537	0.00537	CcSEcCtD
Cefoxitin—Urinary tract disorder—Vincristine—sarcoma	0.00524	0.00524	CcSEcCtD
Cefoxitin—Erythema—Thiotepa—sarcoma	0.00521	0.00521	CcSEcCtD
Cefoxitin—Urethral disorder—Vincristine—sarcoma	0.0052	0.0052	CcSEcCtD
Cefoxitin—Haemoglobin—Mitoxantrone—sarcoma	0.00519	0.00519	CcSEcCtD
Cefoxitin—Erythema—Dactinomycin—sarcoma	0.00517	0.00517	CcSEcCtD
Cefoxitin—Haemorrhage—Mitoxantrone—sarcoma	0.00517	0.00517	CcSEcCtD
Cefoxitin—Pancytopenia—Etoposide—sarcoma	0.0051	0.0051	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Epirubicin—sarcoma	0.00507	0.00507	CcSEcCtD
Cefoxitin—Neutropenia—Etoposide—sarcoma	0.00502	0.00502	CcSEcCtD
Cefoxitin—Anaemia—Thiotepa—sarcoma	0.00481	0.00481	CcSEcCtD
Cefoxitin—Vaginal inflammation—Epirubicin—sarcoma	0.0048	0.0048	CcSEcCtD
Cefoxitin—Anaemia—Dactinomycin—sarcoma	0.00478	0.00478	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Etoposide—sarcoma	0.00475	0.00475	CcSEcCtD
Cefoxitin—Blood bilirubin increased—Doxorubicin—sarcoma	0.00469	0.00469	CcSEcCtD
Cefoxitin—Jaundice—Etoposide—sarcoma	0.00467	0.00467	CcSEcCtD
Cefoxitin—Leukopenia—Thiotepa—sarcoma	0.00466	0.00466	CcSEcCtD
Cefoxitin—Leukopenia—Dactinomycin—sarcoma	0.00463	0.00463	CcSEcCtD
Cefoxitin—Colitis—Epirubicin—sarcoma	0.00461	0.00461	CcSEcCtD
Cefoxitin—Candida infection—Epirubicin—sarcoma	0.00458	0.00458	CcSEcCtD
Cefoxitin—Vaginal infection—Epirubicin—sarcoma	0.00453	0.00453	CcSEcCtD
Cefoxitin—Convulsion—Thiotepa—sarcoma	0.00451	0.00451	CcSEcCtD
Cefoxitin—Aplastic anaemia—Epirubicin—sarcoma	0.0045	0.0045	CcSEcCtD
Cefoxitin—Erythema—Mitoxantrone—sarcoma	0.0045	0.0045	CcSEcCtD
Cefoxitin—Agranulocytosis—Etoposide—sarcoma	0.00447	0.00447	CcSEcCtD
Cefoxitin—Vaginal inflammation—Doxorubicin—sarcoma	0.00444	0.00444	CcSEcCtD
Cefoxitin—Rash maculo-papular—Epirubicin—sarcoma	0.00436	0.00436	CcSEcCtD
Cefoxitin—Anaemia—Vincristine—sarcoma	0.00427	0.00427	CcSEcCtD
Cefoxitin—Colitis—Doxorubicin—sarcoma	0.00426	0.00426	CcSEcCtD
Cefoxitin—Urinary tract disorder—Etoposide—sarcoma	0.00424	0.00424	CcSEcCtD
Cefoxitin—Candida infection—Doxorubicin—sarcoma	0.00424	0.00424	CcSEcCtD
Cefoxitin—Urethral disorder—Etoposide—sarcoma	0.00421	0.00421	CcSEcCtD
Cefoxitin—Vaginal infection—Doxorubicin—sarcoma	0.00419	0.00419	CcSEcCtD
Cefoxitin—Aplastic anaemia—Doxorubicin—sarcoma	0.00417	0.00417	CcSEcCtD
Cefoxitin—Thrombocytopenia—Thiotepa—sarcoma	0.00416	0.00416	CcSEcCtD
Cefoxitin—Anaemia—Mitoxantrone—sarcoma	0.00416	0.00416	CcSEcCtD
Cefoxitin—Leukopenia—Vincristine—sarcoma	0.00413	0.00413	CcSEcCtD
Cefoxitin—Thrombocytopenia—Dactinomycin—sarcoma	0.00413	0.00413	CcSEcCtD
Cefoxitin—Erythema multiforme—Etoposide—sarcoma	0.00406	0.00406	CcSEcCtD
Cefoxitin—Phlebitis—Epirubicin—sarcoma	0.00404	0.00404	CcSEcCtD
Cefoxitin—Rash maculo-papular—Doxorubicin—sarcoma	0.00403	0.00403	CcSEcCtD
Cefoxitin—Leukopenia—Mitoxantrone—sarcoma	0.00403	0.00403	CcSEcCtD
Cefoxitin—Thrombophlebitis—Epirubicin—sarcoma	0.00402	0.00402	CcSEcCtD
Cefoxitin—Convulsion—Vincristine—sarcoma	0.004	0.004	CcSEcCtD
Cefoxitin—Flushing—Etoposide—sarcoma	0.00399	0.00399	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Epirubicin—sarcoma	0.00398	0.00398	CcSEcCtD
Cefoxitin—Convulsion—Mitoxantrone—sarcoma	0.0039	0.0039	CcSEcCtD
Cefoxitin—Renal failure acute—Epirubicin—sarcoma	0.00377	0.00377	CcSEcCtD
Cefoxitin—Anaphylactic shock—Vincristine—sarcoma	0.00377	0.00377	CcSEcCtD
Cefoxitin—Phlebitis—Doxorubicin—sarcoma	0.00374	0.00374	CcSEcCtD
Cefoxitin—Thrombophlebitis—Doxorubicin—sarcoma	0.00372	0.00372	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Epirubicin—sarcoma	0.00369	0.00369	CcSEcCtD
Cefoxitin—Thrombocytopenia—Vincristine—sarcoma	0.00369	0.00369	CcSEcCtD
Cefoxitin—Hepatic function abnormal—Doxorubicin—sarcoma	0.00369	0.00369	CcSEcCtD
Cefoxitin—Anaphylactic shock—Mitoxantrone—sarcoma	0.00367	0.00367	CcSEcCtD
Cefoxitin—Pain—Thiotepa—sarcoma	0.00363	0.00363	CcSEcCtD
Cefoxitin—Pain—Dactinomycin—sarcoma	0.00361	0.00361	CcSEcCtD
Cefoxitin—Thrombocytopenia—Mitoxantrone—sarcoma	0.00359	0.00359	CcSEcCtD
Cefoxitin—Hypotension—Vincristine—sarcoma	0.00352	0.00352	CcSEcCtD
Cefoxitin—Renal failure acute—Doxorubicin—sarcoma	0.00349	0.00349	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Thiotepa—sarcoma	0.00348	0.00348	CcSEcCtD
Cefoxitin—Anaemia—Etoposide—sarcoma	0.00346	0.00346	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Dactinomycin—sarcoma	0.00345	0.00345	CcSEcCtD
Cefoxitin—Hypotension—Mitoxantrone—sarcoma	0.00343	0.00343	CcSEcCtD
Cefoxitin—Dermatitis exfoliative—Doxorubicin—sarcoma	0.00341	0.00341	CcSEcCtD
Cefoxitin—Urticaria—Thiotepa—sarcoma	0.00338	0.00338	CcSEcCtD
Cefoxitin—Abdominal pain—Thiotepa—sarcoma	0.00336	0.00336	CcSEcCtD
Cefoxitin—Body temperature increased—Thiotepa—sarcoma	0.00336	0.00336	CcSEcCtD
Cefoxitin—Leukopenia—Etoposide—sarcoma	0.00335	0.00335	CcSEcCtD
Cefoxitin—Abdominal pain—Dactinomycin—sarcoma	0.00333	0.00333	CcSEcCtD
Cefoxitin—Body temperature increased—Dactinomycin—sarcoma	0.00333	0.00333	CcSEcCtD
Cefoxitin—Dyspnoea—Mitoxantrone—sarcoma	0.00327	0.00327	CcSEcCtD
Cefoxitin—Convulsion—Etoposide—sarcoma	0.00324	0.00324	CcSEcCtD
Cefoxitin—Pain—Vincristine—sarcoma	0.00322	0.00322	CcSEcCtD
Cefoxitin—Pain—Mitoxantrone—sarcoma	0.00314	0.00314	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.00314	0.00314	CcSEcCtD
Cefoxitin—Hypersensitivity—Thiotepa—sarcoma	0.00313	0.00313	CcSEcCtD
Cefoxitin—Hypersensitivity—Dactinomycin—sarcoma	0.00311	0.00311	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Vincristine—sarcoma	0.00308	0.00308	CcSEcCtD
Cefoxitin—Anaphylactic shock—Etoposide—sarcoma	0.00305	0.00305	CcSEcCtD
Cefoxitin—Pruritus—Thiotepa—sarcoma	0.00301	0.00301	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Mitoxantrone—sarcoma	0.003	0.003	CcSEcCtD
Cefoxitin—Thrombocytopenia—Etoposide—sarcoma	0.00299	0.00299	CcSEcCtD
Cefoxitin—Eosinophilia—Epirubicin—sarcoma	0.00298	0.00298	CcSEcCtD
Cefoxitin—Abdominal pain—Vincristine—sarcoma	0.00298	0.00298	CcSEcCtD
Cefoxitin—Body temperature increased—Vincristine—sarcoma	0.00298	0.00298	CcSEcCtD
Cefoxitin—Urticaria—Mitoxantrone—sarcoma	0.00292	0.00292	CcSEcCtD
Cefoxitin—Diarrhoea—Thiotepa—sarcoma	0.00291	0.00291	CcSEcCtD
Cefoxitin—Abdominal pain—Mitoxantrone—sarcoma	0.0029	0.0029	CcSEcCtD
Cefoxitin—Body temperature increased—Mitoxantrone—sarcoma	0.0029	0.0029	CcSEcCtD
Cefoxitin—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.0029	0.0029	CcSEcCtD
Cefoxitin—Diarrhoea—Dactinomycin—sarcoma	0.00289	0.00289	CcSEcCtD
Cefoxitin—Pancytopenia—Epirubicin—sarcoma	0.00286	0.00286	CcSEcCtD
Cefoxitin—Hypotension—Etoposide—sarcoma	0.00285	0.00285	CcSEcCtD
Cefoxitin—Neutropenia—Epirubicin—sarcoma	0.00281	0.00281	CcSEcCtD
Cefoxitin—Hypersensitivity—Vincristine—sarcoma	0.00278	0.00278	CcSEcCtD
Cefoxitin—Eosinophilia—Doxorubicin—sarcoma	0.00276	0.00276	CcSEcCtD
Cefoxitin—Dyspnoea—Etoposide—sarcoma	0.00272	0.00272	CcSEcCtD
Cefoxitin—Hypersensitivity—Mitoxantrone—sarcoma	0.0027	0.0027	CcSEcCtD
Cefoxitin—Vomiting—Thiotepa—sarcoma	0.0027	0.0027	CcSEcCtD
Cefoxitin—Vomiting—Dactinomycin—sarcoma	0.00268	0.00268	CcSEcCtD
Cefoxitin—Rash—Thiotepa—sarcoma	0.00268	0.00268	CcSEcCtD
Cefoxitin—Dermatitis—Thiotepa—sarcoma	0.00268	0.00268	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Epirubicin—sarcoma	0.00266	0.00266	CcSEcCtD
Cefoxitin—Rash—Dactinomycin—sarcoma	0.00266	0.00266	CcSEcCtD
Cefoxitin—Pancytopenia—Doxorubicin—sarcoma	0.00264	0.00264	CcSEcCtD
Cefoxitin—Jaundice—Epirubicin—sarcoma	0.00262	0.00262	CcSEcCtD
Cefoxitin—Pain—Etoposide—sarcoma	0.00261	0.00261	CcSEcCtD
Cefoxitin—Neutropenia—Doxorubicin—sarcoma	0.0026	0.0026	CcSEcCtD
Cefoxitin—Diarrhoea—Vincristine—sarcoma	0.00258	0.00258	CcSEcCtD
Cefoxitin—Nausea—Thiotepa—sarcoma	0.00252	0.00252	CcSEcCtD
Cefoxitin—Diarrhoea—Mitoxantrone—sarcoma	0.00251	0.00251	CcSEcCtD
Cefoxitin—Nausea—Dactinomycin—sarcoma	0.00251	0.00251	CcSEcCtD
Cefoxitin—Agranulocytosis—Epirubicin—sarcoma	0.0025	0.0025	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Etoposide—sarcoma	0.0025	0.0025	CcSEcCtD
Cefoxitin—Stevens-Johnson syndrome—Doxorubicin—sarcoma	0.00246	0.00246	CcSEcCtD
Cefoxitin—Urticaria—Etoposide—sarcoma	0.00243	0.00243	CcSEcCtD
Cefoxitin—Haemoglobin—Epirubicin—sarcoma	0.00242	0.00242	CcSEcCtD
Cefoxitin—Jaundice—Doxorubicin—sarcoma	0.00242	0.00242	CcSEcCtD
Cefoxitin—Abdominal pain—Etoposide—sarcoma	0.00241	0.00241	CcSEcCtD
Cefoxitin—Body temperature increased—Etoposide—sarcoma	0.00241	0.00241	CcSEcCtD
Cefoxitin—Haemorrhage—Epirubicin—sarcoma	0.00241	0.00241	CcSEcCtD
Cefoxitin—Vomiting—Vincristine—sarcoma	0.0024	0.0024	CcSEcCtD
Cefoxitin—Urinary tract disorder—Epirubicin—sarcoma	0.00238	0.00238	CcSEcCtD
Cefoxitin—Rash—Vincristine—sarcoma	0.00238	0.00238	CcSEcCtD
Cefoxitin—Dermatitis—Vincristine—sarcoma	0.00237	0.00237	CcSEcCtD
Cefoxitin—Urethral disorder—Epirubicin—sarcoma	0.00236	0.00236	CcSEcCtD
Cefoxitin—Vomiting—Mitoxantrone—sarcoma	0.00233	0.00233	CcSEcCtD
Cefoxitin—Agranulocytosis—Doxorubicin—sarcoma	0.00232	0.00232	CcSEcCtD
Cefoxitin—Rash—Mitoxantrone—sarcoma	0.00231	0.00231	CcSEcCtD
Cefoxitin—Dermatitis—Mitoxantrone—sarcoma	0.00231	0.00231	CcSEcCtD
Cefoxitin—Erythema multiforme—Epirubicin—sarcoma	0.00228	0.00228	CcSEcCtD
Cefoxitin—Hypersensitivity—Etoposide—sarcoma	0.00225	0.00225	CcSEcCtD
Cefoxitin—Haemoglobin—Doxorubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Cefoxitin—Nausea—Vincristine—sarcoma	0.00224	0.00224	CcSEcCtD
Cefoxitin—Flushing—Epirubicin—sarcoma	0.00224	0.00224	CcSEcCtD
Cefoxitin—Haemorrhage—Doxorubicin—sarcoma	0.00223	0.00223	CcSEcCtD
Cefoxitin—Urinary tract disorder—Doxorubicin—sarcoma	0.0022	0.0022	CcSEcCtD
Cefoxitin—Urethral disorder—Doxorubicin—sarcoma	0.00218	0.00218	CcSEcCtD
Cefoxitin—Nausea—Mitoxantrone—sarcoma	0.00218	0.00218	CcSEcCtD
Cefoxitin—Pruritus—Etoposide—sarcoma	0.00216	0.00216	CcSEcCtD
Cefoxitin—Erythema multiforme—Doxorubicin—sarcoma	0.00211	0.00211	CcSEcCtD
Cefoxitin—Erythema—Epirubicin—sarcoma	0.0021	0.0021	CcSEcCtD
Cefoxitin—Diarrhoea—Etoposide—sarcoma	0.00209	0.00209	CcSEcCtD
Cefoxitin—Flushing—Doxorubicin—sarcoma	0.00207	0.00207	CcSEcCtD
Cefoxitin—Vomiting—Etoposide—sarcoma	0.00194	0.00194	CcSEcCtD
Cefoxitin—Erythema—Doxorubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Cefoxitin—Anaemia—Epirubicin—sarcoma	0.00194	0.00194	CcSEcCtD
Cefoxitin—Rash—Etoposide—sarcoma	0.00193	0.00193	CcSEcCtD
Cefoxitin—Dermatitis—Etoposide—sarcoma	0.00192	0.00192	CcSEcCtD
Cefoxitin—Leukopenia—Epirubicin—sarcoma	0.00188	0.00188	CcSEcCtD
Cefoxitin—Convulsion—Epirubicin—sarcoma	0.00182	0.00182	CcSEcCtD
Cefoxitin—Nausea—Etoposide—sarcoma	0.00181	0.00181	CcSEcCtD
Cefoxitin—Anaemia—Doxorubicin—sarcoma	0.00179	0.00179	CcSEcCtD
Cefoxitin—Leukopenia—Doxorubicin—sarcoma	0.00174	0.00174	CcSEcCtD
Cefoxitin—Anaphylactic shock—Epirubicin—sarcoma	0.00171	0.00171	CcSEcCtD
Cefoxitin—Convulsion—Doxorubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Cefoxitin—Thrombocytopenia—Epirubicin—sarcoma	0.00168	0.00168	CcSEcCtD
Cefoxitin—Hypotension—Epirubicin—sarcoma	0.0016	0.0016	CcSEcCtD
Cefoxitin—Anaphylactic shock—Doxorubicin—sarcoma	0.00158	0.00158	CcSEcCtD
Cefoxitin—Thrombocytopenia—Doxorubicin—sarcoma	0.00155	0.00155	CcSEcCtD
Cefoxitin—Dyspnoea—Epirubicin—sarcoma	0.00153	0.00153	CcSEcCtD
Cefoxitin—Hypotension—Doxorubicin—sarcoma	0.00148	0.00148	CcSEcCtD
Cefoxitin—Pain—Epirubicin—sarcoma	0.00146	0.00146	CcSEcCtD
Cefoxitin—Dyspnoea—Doxorubicin—sarcoma	0.00141	0.00141	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Epirubicin—sarcoma	0.0014	0.0014	CcSEcCtD
Cefoxitin—Urticaria—Epirubicin—sarcoma	0.00136	0.00136	CcSEcCtD
Cefoxitin—Pain—Doxorubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Cefoxitin—Abdominal pain—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Cefoxitin—Body temperature increased—Epirubicin—sarcoma	0.00135	0.00135	CcSEcCtD
Cefoxitin—Gastrointestinal pain—Doxorubicin—sarcoma	0.00129	0.00129	CcSEcCtD
Cefoxitin—Hypersensitivity—Epirubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Cefoxitin—Urticaria—Doxorubicin—sarcoma	0.00126	0.00126	CcSEcCtD
Cefoxitin—Body temperature increased—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Cefoxitin—Abdominal pain—Doxorubicin—sarcoma	0.00125	0.00125	CcSEcCtD
Cefoxitin—Pruritus—Epirubicin—sarcoma	0.00121	0.00121	CcSEcCtD
Cefoxitin—Diarrhoea—Epirubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Cefoxitin—Hypersensitivity—Doxorubicin—sarcoma	0.00117	0.00117	CcSEcCtD
Cefoxitin—Pruritus—Doxorubicin—sarcoma	0.00112	0.00112	CcSEcCtD
Cefoxitin—Vomiting—Epirubicin—sarcoma	0.00109	0.00109	CcSEcCtD
Cefoxitin—Diarrhoea—Doxorubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Cefoxitin—Rash—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Cefoxitin—Dermatitis—Epirubicin—sarcoma	0.00108	0.00108	CcSEcCtD
Cefoxitin—Nausea—Epirubicin—sarcoma	0.00102	0.00102	CcSEcCtD
Cefoxitin—Vomiting—Doxorubicin—sarcoma	0.00101	0.00101	CcSEcCtD
Cefoxitin—Rash—Doxorubicin—sarcoma	0.000998	0.000998	CcSEcCtD
Cefoxitin—Dermatitis—Doxorubicin—sarcoma	0.000998	0.000998	CcSEcCtD
Cefoxitin—Nausea—Doxorubicin—sarcoma	0.000941	0.000941	CcSEcCtD
